Zink, Florian
Magnusdottir, Droplaug N.
Magnusson, Olafur T.
Walker, Nicolas J.
Morris, Tiffany J.
Sigurdsson, Asgeir
Halldorsson, Gisli H. https://orcid.org/0000-0001-7067-9862
Gudjonsson, Sigurjon A.
Melsted, Pall
Ingimundardottir, Helga https://orcid.org/0000-0002-2780-3546
Kristmundsdottir, Snædis
Alexandersson, Kristjan F.
Helgadottir, Anna https://orcid.org/0000-0002-1806-2467
Gudmundsson, Julius
Rafnar, Thorunn https://orcid.org/0000-0003-0491-7046
Jonsdottir, Ingileif https://orcid.org/0000-0001-8339-150X
Holm, Hilma
Eyjolfsson, Gudmundur Ingi
Sigurdardottir, Olof
Olafsson, Isleifur
Masson, Gisli
Gudbjartsson, Daniel F. https://orcid.org/0000-0002-5222-9857
Thorsteinsdottir, Unnur
Halldorsson, Bjarni V. https://orcid.org/0000-0003-0756-0767
Stacey, Simon N. https://orcid.org/0000-0002-4732-7380
Stefansson, Kari
Article History
Received: 7 February 2018
Accepted: 8 August 2018
First Online: 22 October 2018
Competing interests
: All deCODE authors are employees of the biotechnology company deCODE genetics/AMGEN. N.J.W. and T.J.M. are employees of Cambridge Epigenetix Ltd. Cambridge Epigenetix Ltd retains the rights for diagnostic use of the oxBS-seq technology and receives royalties from the sale of oxBS kits under the terms of a partnership agreement with NuGEN Technologies.